Meningococcal Vaccination

Your questions answered

Translate to Spanish or other 102 languages!

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes
Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes

Mega Doctor News

- Advertisement -

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health.

There are two types of meningococcal vaccines licensed in the United States:

  • Meningococcal conjugate (MenACWY) vaccines
  • Serogroup B meningococcal (MenB) vaccines

These vaccines help prevent the most common causes of meningococcal disease in the United States.

- Advertisement -

CDC recommends meningococcal vaccines for preteens, teens, and certain other people

CDC recommends MenACWY vaccine for:

  • All preteens at 11 to 12 years old
  • All teens at 16 years old

The booster dose at 16 years old gives teens continued protection during the ages when they are at highest risk.

Teens and young adults (16 through 23 year olds) may also get MenB vaccine.

  • Preferred age is 16 through 18 years old
  • Multiple doses needed for best protection
  • Must get the same brand for all doses

Younger children and adults usually do not need meningococcal vaccines. However, CDC recommends one or both types of meningococcal vaccines for people with

- Advertisement -
  • Certain medical conditions
  • Travel plans to areas where the disease is common
  • Jobs working with the bacteria
  • Increased risk due to a meningococcal disease outbreak

Meningococcal vaccines are safe but side effects can occur

About half of people who get a MenACWY vaccine have mild problems following vaccination:

  • Redness or pain where they got the shot
  • Fever

These reactions usually get better on their own within 1 to 2 days, but serious reactions are possible.

Following MenB vaccination, more than half of people who get the vaccine will have mild problems:

  • Soreness, redness, or swelling where they got the shot
  • Fatigue (tiredness)
  • Headache
  • Muscle or joint pain
  • Fever or chills
  • Nausea or diarrhea

These reactions usually get better on their own within 3 to 7 days, but serious reactions are possible.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Robotic Innovation is Transforming Breast Cancer Surgery

October is Breast Cancer Awareness Month. Reports show one in eight women in the United States will develop breast cancer, and some may have to undergo a mastectomy, which can now be performed robotically.

South Padre Island Steps Up for Breast Cancer Awareness at 2026 Walk for Women, Oct. 4th

South Padre Island will come together in a show of hope, strength and support on Sunday, October 4, for the annual Walk for Breast Cancer Awareness, benefiting South Padre Island’s Walk for Women and its mission to help Rio Grande Valley women and families affected by breast cancer.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.
- Advertisement -